Genetic Carrier Screening

"Genetic Carrier Screening" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus, MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure, which enables searching at various levels of specificity.

MeSH information

Definition | Details | More General Concepts | Related Concepts | More Specific Concepts

Identification of individuals who are heterozygous at a GENETIC LOCUS for a recessive PHENOTYPE.

Descriptor ID	D006580
MeSH Number(s)	E01.370.225.562.250 E05.200.562.250 E05.393.435.250 N02.421.308.200 N02.421.726.233.221.250
Concept/Terms	Genetic Carrier Screening Genetic Carrier Screening Carrier Screening, Genetic Screening, Genetic Carrier Screenings, Genetic Carrier Carrier Detection, Genetic Heterozygote Detection Detection, Heterozygote Genetic Carrier Detection Carriers, Genetic, Detection Genetic Carriers, Detection Heterozygote Screening Screening, Heterozygote Detection, Genetic Carrier

Below are MeSH descriptors whose meaning is more general than "Genetic Carrier Screening".

Analytical, Diagnostic and Therapeutic Techniques and Equipment [E]
Diagnosis [E01]
Diagnostic Techniques and Procedures [E01.370]
Clinical Laboratory Techniques [E01.370.225]
Genetic Testing [E01.370.225.562]
Genetic Carrier Screening [E01.370.225.562.250]
Investigative Techniques [E05]
Clinical Laboratory Techniques [E05.200]
Genetic Testing [E05.200.562]
Genetic Carrier Screening [E05.200.562.250]
Genetic Techniques [E05.393]
Genetic Testing [E05.393.435]
Genetic Carrier Screening [E05.393.435.250]
Health Care [N]
Health Care Facilities, Manpower, and Services [N02]
Health Services [N02.421]
Genetic Services [N02.421.308]
Genetic Carrier Screening [N02.421.308.200]
Preventive Health Services [N02.421.726]
Diagnostic Services [N02.421.726.233]
Genetic Testing [N02.421.726.233.221]
Genetic Carrier Screening [N02.421.726.233.221.250]

Below are MeSH descriptors whose meaning is related to "Genetic Carrier Screening".

Below are MeSH descriptors whose meaning is more specific than "Genetic Carrier Screening".

publications

Timeline | Most Recent

This graph shows the total number of publications written about "Genetic Carrier Screening" by people in this website by year, and whether "Genetic Carrier Screening" was a major or minor topic of these publications.

Bar chart showing 20 publications over 15 distinct years, with a maximum of 3 publications in 2003 and 2006

To see the data from this visualization as text, click here.

Year	Major Topic	Minor Topic	Total
1995	0	1	1
1998	0	1	1
2001	0	1	1
2003	0	3	3
2004	1	0	1
2005	0	1	1
2006	1	2	3
2007	0	1	1
2008	0	2	2
2010	0	1	1
2012	0	1	1
2013	0	1	1
2015	1	0	1
2017	1	0	1
2018	1	0	1

Below are the most recent publications written about "Genetic Carrier Screening" by people in Profiles.

Brown KL, Flume PA. Pediatric and Adult Recommendations Vary for Sibling Testing in Cystic Fibrosis. J Genet Couns. 2018 09; 27(5):1049-1054.

View in: PubMed
Shiroff JJ, Gregoski MJ. The measurement of patient attitudes regarding prenatal and preconception genetic carrier screening and translational behavioral medicine: an integrative review. Transl Behav Med. 2017 06; 7(2):364-370.

View in: PubMed
Shiroff JJ, Nemeth LS. Public Perceptions of Recessive Carrier Testing in the Preconception and Prenatal Periods. J Obstet Gynecol Neonatal Nurs. 2015 Nov-Dec; 44(6):717-25.

View in: PubMed
Sutter AG, Palanisamy AP, Kurtz N, Spyropoulos DD, Chavin KD. Efficient method of genotyping ob/ob mice using high resolution melting analysis. PLoS One. 2013; 8(11):e78840.

View in: PubMed
Keary TA, Gunstad J, Benitez A, Spitznagel MB, McCaffery J, McGeary JE, Poppas A, Paul RH, Sweet LH, Cohen RA. TCF7L2 polymorphism and cognitive test performance in cardiovascular disease. Psychogeriatrics. 2012 Jun; 12(2):93-8.

View in: PubMed
Walsh MD, Buchanan DD, Cummings MC, Pearson SA, Arnold ST, Clendenning M, Walters R, McKeone DM, Spurdle AB, Hopper JL, Jenkins MA, Phillips KD, Suthers GK, George J, Goldblatt J, Muir A, Tucker K, Pelzer E, Gattas MR, Woodall S, Parry S, Macrae FA, Haile RW, Baron JA, Potter JD, Le Marchand L, Bapat B, Thibodeau SN, Lindor NM, McGuckin MA, Young JP. Lynch syndrome-associated breast cancers: clinicopathologic characteristics of a case series from the colon cancer family registry. Clin Cancer Res. 2010 Apr 01; 16(7):2214-24.

View in: PubMed
Prober DA, Zimmerman S, Myers BR, McDermott BM, Kim SH, Caron S, Rihel J, Solnica-Krezel L, Julius D, Hudspeth AJ, Schier AF. Zebrafish TRPA1 channels are required for chemosensation but not for thermosensation or mechanosensory hair cell function. J Neurosci. 2008 Oct 01; 28(40):10102-10.

View in: PubMed
Anton RF, Oroszi G, O'Malley S, Couper D, Swift R, Pettinati H, Goldman D. An evaluation of mu-opioid receptor (OPRM1) as a predictor of naltrexone response in the treatment of alcohol dependence: results from the Combined Pharmacotherapies and Behavioral Interventions for Alcohol Dependence (COMBINE) study. Arch Gen Psychiatry. 2008 Feb; 65(2):135-44.

View in: PubMed
Carpenter MJ, Strange C, Jones Y, Dickson MR, Carter C, Moseley MA, Gilbert GE. Does genetic testing result in behavioral health change? Changes in smoking behavior following testing for alpha-1 antitrypsin deficiency. Ann Behav Med. 2007 Feb; 33(1):22-8.

View in: PubMed
Muratori P, Sutherland SE, Muratori L, Granito A, Guidi M, Pappas G, Lenzi M, Bianchi FB, Pandey JP. Immunoglobulin GM and KM allotypes and prevalence of anti-LKM1 autoantibodies in patients with hepatitis C virus infection. J Virol. 2006 May; 80(10):5097-9.

View in: PubMed

People

Explore

Similar Concepts

Top Journals